首页> 外文期刊>Tetrahedron >Synthesis of a tricyclic tetraazatriacetic ligand for gadolinium(III) as potential contrast agent for MRI
【24h】

Synthesis of a tricyclic tetraazatriacetic ligand for gadolinium(III) as potential contrast agent for MRI

机译:cyclic(III)的三环四氮杂三乙酸配体的合成作为MRI的潜在造影剂

获取原文
获取原文并翻译 | 示例
           

摘要

A tricyclic tetraazatriacetic compound, which is a rigidified derivative of PCTA12 ligand with a cyclohexylene bridge replacing an ethylene one, was prepared. Two synthetic routes have been investigated, both of them implying a common functionalized triamine intermediate. Whatever the route, four synthetic steps were necessary to obtain the target tricyclic ligand. The more effective one (Route B) led to the desired compound in 19% overall yield from the triamine intermediate. The corresponding gadolinium complex of 1/1 stoichiometry was then prepared in order to evaluate it as potential contrast agent for MRI. (c) 2006 Elsevier Ltd. All rights reserved.
机译:制备了三环四氮杂三乙酸化合物,其是PCTA12配体的刚性衍生物,具有取代亚乙基的亚环己基桥。已经研究了两种合成途径,它们都暗示了一种通用的官能化三胺中间体。无论采用哪种途径,都需要四个合成步骤才能获得目标三环配体。一种更有效的方法(路线B)从三胺中间体中以19%的总收率得到了所需化合物。然后制备相应的化学计量比为1/1的g络合物,以评价其作为MRI的潜在造影剂。 (c)2006 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号